CASUS vs. APACHE II in Predicting Mortality After Coronary Artery Bypass Grafting

Completed

• Conditions: Coronary Artery Bypass Grafting; Mortality

• Registration Number: NCT05026437
• Lead Sponsor: Antalya Training and Research Hospital

Brief Summary

The study seeks to determine the value of CASUS in predicting mortality as compared with APACHE II scoring system among patients undergoing coronary artery bypass grafting.

Detailed Description

Patients undergoing coronary artery bypass grafting will prospectively studied after the admission to the cardiac intensive care unit. Data on the preoperative condition, intraoperative parameters, and postoperative course will collected. CASUS and APACHE II scores will calculated on the first postoperative day. Clinical outcomes are defined as 7-day mortality, 30-day mortality and morbidity. Morbidity includes variables such as length of stay in the cardiac surgical intensive care unit and in the hospital.

Study Timeline

• Study Start: 2019-01-02
• Study First Submitted: 2019-01-23
• Primary Completion: 2019-03-10
• Study Completion: 2019-04-10
• Status Verified: 2021-08
• Study First Submitted QC: 2021-08-23
• Last Update Submitted: 2021-08-23
• Study First Posted: 2021-08-30
• Last Update Posted: 2021-08-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 204

Inclusion Criteria

• Undergoing coronary artery bypass grafting
• Over 18 years of age
• Staying at least 24 hours in the cardiac intensive care unit

Exclusion Criteria

• Emergency surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality at 7 days	7 days	Mortality in the first 7 days after surgery
Mortality at 30 days	30 days	Mortality in the first 30 days after surgery

Secondary Outcome Measures

Name	Time	Method
Length of stay in the cardiac intensive care unit	Up to 3 months (Through study completion)	Only the length of the initial stay in the cardiac intensive care unit up to 3 months
Length of the stay in the hospital	Up to 3 months (Through study completion)	It includes the period from surgery to discharge

Trial Locations

Locations (2)

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital in Turkey; 🇹🇷 Istanbul, Turkey

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital; 🇹🇷 Istanbul, Turkey